Why subscribe to the Longevity Marketcap Newsletter?

Subscribe to get full access to timely longevity biotechnology investment and trading analysis.

Early subscribers get full access including:

  • Longevity biotech fundamental research and technical analysis — every Monday.

  • Top longevity market investment research and strategies

  • News, upcoming events, and major developments in longevity biotechnology

  • Access to future biotech livestream trading and podcasts

Stay up-to-date

You won’t have to worry about missing anything. Every new edition of the newsletter goes directly to your inbox.

Join the early adopters crew

Be part of the community of longevity investors — futurist thinkers and investors just like you.

Comment and discuss longevity biotech investing ideas and strategies right here on the LongevityMarketcap Substack.

About the author

Nathan Cheng is an entrepreneur, longevity biotechnology advocate, and investor based in Toronto, Canada.

In 2012, he was in the middle of completing a Ph.D in physics (Quantum Optics) at the University of Toronto but dropped out due to an existential meltdown. After several years of wandering as a digital nomad backpacker he discovered the works of Aubrey de Grey and the longevity movement, which would eventually become his sole mission in life.

Subscribe to Longevity Marketcap Newsletter

Investing in the Longevity Biotechnology Revolution. By Nathan Cheng + Longevity List.


I write about investing in longevity biotechnology. My mission: End Aging. - Co-executive Director of The Longevity Biotech Fellowship. - General Partner @ Healthspan Capital - Founder @ LongevityList.com - Founder at Vitalism.io